{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T13:34:57Z","timestamp":1782480897348,"version":"3.54.5"},"reference-count":66,"publisher":"BMJ","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.n568","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T16:35:11Z","timestamp":1617035711000},"page":"n568","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4024-9308","authenticated-orcid":false,"given":"Jenny A","family":"Doust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy J L","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska M G","family":"Leeflang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Dinnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally J","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Mallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke H H M","family":"van de Wijgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khosrow","family":"Adeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"2021032913350492000_372.mar29_9.n568.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"2021032913350492000_372.mar29_9.n568.2","unstructured":"Zhang Y-Z. Novel 2019 coronavirus genome. Virological 2020. https:\/\/virological.org\/t\/novel-2019-coronavirus-genome\/319"},{"key":"2021032913350492000_372.mar29_9.n568.3","unstructured":"Foundation for Innovative New Diagnostics . Homepage. 2021 https:\/\/www.finddx.org\/covid-19\/"},{"key":"2021032913350492000_372.mar29_9.n568.4","unstructured":"European Commission. JRC Covid-19 In Vitro Diagnostic Devices and Test Methods. https:\/\/covid-19-diagnostics.jrc.ec.europa.eu\/"},{"key":"2021032913350492000_372.mar29_9.n568.5","unstructured":"Norwegian Institute of Public Health. NIPH systematic and living map on COVID-19 evidence. https:\/\/www.nornesk.no\/forskningskart\/NIPH_diagnosisMap.html"},{"key":"2021032913350492000_372.mar29_9.n568.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr2022263"},{"key":"2021032913350492000_372.mar29_9.n568.7","unstructured":"National Institute for Health and Care Excellence. Diagnostic tests for COVID-19 \u2013 Evidence Standards Framework. https:\/\/www.nice.org.uk\/Media\/Default\/About\/what-we-do\/covid-19\/Diagnostic-tests-for-COVID-19-evidence-standards-framework.pdf."},{"key":"2021032913350492000_372.mar29_9.n568.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527"},{"key":"2021032913350492000_372.mar29_9.n568.9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013652"},{"key":"2021032913350492000_372.mar29_9.n568.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2516"},{"key":"2021032913350492000_372.mar29_9.n568.11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10050319"},{"key":"2021032913350492000_372.mar29_9.n568.12","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01810-8"},{"key":"2021032913350492000_372.mar29_9.n568.13","doi-asserted-by":"crossref","unstructured":"Arevalo-Rodriguez I Buitrago-Garcia D Simancas-Racines D . False negative results of initial RT-PCR assays for COVID-19: a systematic review. medRxiv 2020 [Preprint]. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.04.16.20066787v2.article-info","DOI":"10.1371\/journal.pone.0242958"},{"key":"2021032913350492000_372.mar29_9.n568.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102916"},{"key":"2021032913350492000_372.mar29_9.n568.15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013705"},{"key":"2021032913350492000_372.mar29_9.n568.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4787"},{"key":"2021032913350492000_372.mar29_9.n568.17","doi-asserted-by":"publisher","DOI":"10.1059\/0003-4819-155-8-201110180-00009"},{"key":"2021032913350492000_372.mar29_9.n568.18","unstructured":"US Food and Drug Administration. In Vitro Diagnostics EUAs. 2021. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/vitro-diagnostics-euas"},{"key":"2021032913350492000_372.mar29_9.n568.19","unstructured":"Medicine and Healthcare products Regulatory Agency. Target-Product-Profile-Antibody-Tests-to-Help-Determine-if-People-Have-Recent-Infection-to-SARS-CoV-2-version-2. 2021. https:\/\/www.gov.uk\/government\/publications\/how-tests-and-testing-kits-for-coronavirus-covid-19-work\/target-product-profile-antibody-tests-to-help-determine-if-people-have-recent-infection-to-sars-cov-2-version-2"},{"key":"2021032913350492000_372.mar29_9.n568.20","unstructured":"World Health Organization. Target product profiles for priority diagnostics to support response to the COVID-19 pandemic version 1.0. 2020."},{"key":"2021032913350492000_372.mar29_9.n568.21","unstructured":"European Commission. COVID-19: Recommendations for testing strategies 2020. https:\/\/ec.europa.eu\/info\/sites\/info\/files\/covid19_-_eu_recommendations_on_testing_strategies_v2.pdf"},{"key":"2021032913350492000_372.mar29_9.n568.22","unstructured":"EUR-Lex. Regulation (EU) 2017\/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98\/79\/EC and Commission Decision 2010\/227\/EU. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:02017R0746-20170505"},{"key":"2021032913350492000_372.mar29_9.n568.23","unstructured":"Centers for Disease Control. Interim Guidance for Antigen Testing for SARS-CoV-2. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/resources\/antigen-tests-guidelines.html."},{"key":"2021032913350492000_372.mar29_9.n568.24","unstructured":"Centers for Disease Control. Interim Guidance for COVID-19 Antibody testing. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/resources\/antibody-tests-guidelines.html"},{"key":"2021032913350492000_372.mar29_9.n568.25","unstructured":"Global Harmonization Task Force. Clinical Evidence for IVD medical devices \u2013 Scientific Validity Determination and Performance Evaluation. 2012. http:\/\/www.imdrf.org\/docs\/ghtf\/final\/sg5\/technical-docs\/ghtf-sg5-n7-2012-scientific-validity-determination-evaluation-121102.pdf"},{"key":"2021032913350492000_372.mar29_9.n568.26","unstructured":"Infectious Diseases Society of America. Guidelines on the Diagnosis of COVID-19. 2020. https:\/\/www.idsociety.org\/COVID19guidelines\/dx"},{"key":"2021032913350492000_372.mar29_9.n568.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.16656"},{"key":"2021032913350492000_372.mar29_9.n568.28","doi-asserted-by":"crossref","unstructured":"Wajnberg A Amanat F Firpo A . SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months. medRxiv 2020 [Preprint]. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.07.14.20151126v1","DOI":"10.1101\/2020.07.14.20151126"},{"key":"2021032913350492000_372.mar29_9.n568.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3018"},{"key":"2021032913350492000_372.mar29_9.n568.30","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(20)30157-2"},{"key":"2021032913350492000_372.mar29_9.n568.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2015897"},{"key":"2021032913350492000_372.mar29_9.n568.32","doi-asserted-by":"publisher","DOI":"10.1177\/0004563219842265"},{"key":"2021032913350492000_372.mar29_9.n568.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7549.1089"},{"key":"2021032913350492000_372.mar29_9.n568.34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0869-5"},{"key":"2021032913350492000_372.mar29_9.n568.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x"},{"key":"2021032913350492000_372.mar29_9.n568.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.06.067"},{"key":"2021032913350492000_372.mar29_9.n568.37","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3862"},{"key":"2021032913350492000_372.mar29_9.n568.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026116"},{"key":"2021032913350492000_372.mar29_9.n568.39","doi-asserted-by":"publisher","DOI":"10.1126\/science.369.6504.608"},{"key":"2021032913350492000_372.mar29_9.n568.40","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00796-20"},{"key":"2021032913350492000_372.mar29_9.n568.41","unstructured":"Theel E, Filkins L, Palavecino E, et al. Verification procedure for commercial serologic tests with Emergency Use Authorization for detection of antibodies to SARS-CoV-2. American Society for Microbiology. 2020. https:\/\/asm.org\/Protocols\/Verify-Emergency-Use-Authorization-EUA-SARS-CoV-2."},{"key":"2021032913350492000_372.mar29_9.n568.42","unstructured":"Willman D. Contamination at CDC Laboratory Delayed Rollout of Coronavirus Tests. Washington Post 2020. https:\/\/www.washingtonpost.com\/investigations\/contamination-at-cdc-lab-delayed-rollout-of-coronavirus-tests\/2020\/04\/18\/fd7d3824-7139-11ea-aa80-c2470c6b2034_story.html."},{"key":"2021032913350492000_372.mar29_9.n568.43","unstructured":"Clinical and Laboratory Standards Institute. Harmonized Terminology Database. 2020. https:\/\/htd.clsi.org\/listterms.asp?searchd."},{"key":"2021032913350492000_372.mar29_9.n568.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.11.025"},{"key":"2021032913350492000_372.mar29_9.n568.45","doi-asserted-by":"crossref","unstructured":"Eyre DW, Lumley SF, O\u2019Donnell D, et al. Stringent thresholds for SARS-CoV-2 IgG assays result in underdetection of cases reporting loss of taste\/smell. medRxiv 2020 [Preprint]. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.07.21.20159038v1","DOI":"10.1101\/2020.07.21.20159038"},{"key":"2021032913350492000_372.mar29_9.n568.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.06.037"},{"key":"2021032913350492000_372.mar29_9.n568.47","unstructured":"World Health Organization. Global surveillance for COVID-19 caused by human infection with COVID-19 virus, interim guidance. 20 March 2020"},{"key":"2021032913350492000_372.mar29_9.n568.48","unstructured":"World Health Organization. Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases: interim guidance. 21 March 2020"},{"key":"2021032913350492000_372.mar29_9.n568.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.108961"},{"key":"2021032913350492000_372.mar29_9.n568.50","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1495"},{"key":"2021032913350492000_372.mar29_9.n568.51","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30113-4"},{"key":"2021032913350492000_372.mar29_9.n568.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.05.013"},{"key":"2021032913350492000_372.mar29_9.n568.53","first-page":"161","article-title":"The effect of antigen cross-reaction on testing of SARS-CoV-2 specific antibodies in serum","volume":"3","author":"Zou","year":"2020","journal-title":"Chinese J Clin Lab Sci"},{"key":"2021032913350492000_372.mar29_9.n568.54","unstructured":"Zhang R Li JM . Talking about false positive testing result of SARS-CoV-2 specific antibodies (IgM\/IgG). National Centre for Clinical Laboratories, 2020."},{"key":"2021032913350492000_372.mar29_9.n568.55","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(99)00101-8"},{"key":"2021032913350492000_372.mar29_9.n568.56","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa638"},{"key":"2021032913350492000_372.mar29_9.n568.57","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E"},{"key":"2021032913350492000_372.mar29_9.n568.58","doi-asserted-by":"publisher","DOI":"10.2307\/2276774"},{"key":"2021032913350492000_372.mar29_9.n568.59","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-11-200812020-00009"},{"key":"2021032913350492000_372.mar29_9.n568.60","unstructured":"Food and Drug Administration. EUA Authorized Serology Test Performance. 2021. https:\/\/www.fda.gov\/medical-devices\/emergency-situations-medical-devices\/eua-authorized-serology-test-performance"},{"key":"2021032913350492000_372.mar29_9.n568.61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012799"},{"key":"2021032913350492000_372.mar29_9.n568.62","unstructured":"Loh T. New Tests Could Turn Tide Against Coronavirus if They Work. Bloomberg. 2020. https:\/\/www.bloomberg.com\/news\/articles\/2020-03-31\/new-tests-could-turn-tide-against-coronavirus-if-they-work"},{"key":"2021032913350492000_372.mar29_9.n568.63","unstructured":"Hagemann H. Antibody Tests Go to Market Largely Unregulated Warns House Subcommittee Chair. NPR. 2020. https:\/\/www.npr.org\/sections\/coronavirus-live-updates\/2020\/04\/26\/845164212\/antibody-tests-go-to-market-largely-unregulated-warns-house-subcommittee-chair"},{"key":"2021032913350492000_372.mar29_9.n568.64","unstructured":"Calafiore S. GPs face $20k fines for using serology tests to diagnose coronavirus. 2020. https:\/\/www.rcpa.edu.au\/Library\/COVID-19-Updates\/COVID-19-Useful-Resources\/Docs\/GPs-face-$20k-fines-for-using-serology-tests-to-di.aspx"},{"key":"2021032913350492000_372.mar29_9.n568.65","unstructured":"Gross A, Kelly J. Is the company with a 20-second coronavirus test for real? Financial Times 2020. https:\/\/www.ft.com\/content\/e7a279df-3239-4e00-be29-f38d98f4d730."},{"key":"2021032913350492000_372.mar29_9.n568.66","unstructured":"Bosely S. Claims of 99% accuracy for UK Covid antibody test \u2018cannot be trusted. Guardian 2020. https:\/\/www.theguardian.com\/world\/2020\/aug\/27\/data-secrecy-covid-antibody-test-trusted-fingerprint-doubt"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.n568","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.n568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T20:35:34Z","timestamp":1617050134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.n568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":66,"alternative-id":["10.1136\/bmj.n568"],"URL":"https:\/\/doi.org\/10.1136\/bmj.n568","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]}}}